• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Search Orphan Drug Designations and Approvals

  • Print
  • Share
  • E-mail
-
Generic Name: GCSF-mobilized autologous CD34 cells for intramuscular injection
Date Designated: 03/04/2021
Orphan Designation: Treatment of Buerger's disease (thromboangiitis obliterans)
Orphan Designation Status: Designated/Designation Withdrawn or Revoked
FDA Orphan Approval Status: Not FDA Approved for Orphan Indication
Lisata Therapeutics
110 Allen Road
Second Floor
Basking Ridge, New Jersey 07920
United States

The sponsor address listed is the last reported by the sponsor to OOPD.

*Exclusivity Protected Indications are shown for approvals from 01/01/2013 to the present.
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-
-